PRZOOM - /newswire/ -
Albuquerque, NM, United States, 2010/09/28 - OSO BioPharmaceuticals Manufacturing, LLC, has named Susan Schniepp as vice president of quality.
In managing all operational quality-related issues, Schniepp is responsible for cGMP compliance of OsoBio’s facility. Quality-related matters concerning validation as well as regulatory affairs, records and filings also fall under her scope of responsibility.
Schniepp brings to OsoBio more than 30 years of professional experience managing quality assurance within the pharmaceutical industry.
Recently, Schniepp served as chairwoman of the Monograph Development–Psychiatrics and Psychoactives Expert Committee for United States Pharmacopeia (USP), a non–governmental, official public standards–setting authority for prescription and over–the–counter medicines and other health-care products manufactured or sold in the United States. USP standards for quality, purity, strength and consistency are recognized and used in more than 130 countries.
“Sue is so highly regarded for her expertise in pharmaceutical quality that industry leaders frequently seek out her knowledge and leadership for the benefit of the general public,” said Stuart Rose, president and CEO of OsoBio. “Sue is a great addition to the OsoBio team and an asset to the clients we serve.”
Prior to joining OsoBio, Schniepp worked in quality affairs at Abbott Labs, Antisoma PLC, Hospira and Javelin Pharmaceuticals Inc.
Schniepp is an active member of the Parenteral Drug Association (PDA), for which she has served on numerous committees and been a featured speaker at events. She received the PDA’s Distinguished Author Award for her book, Understanding the United States Pharmacopeia and the National Formulary: Demystifying the Standards-Setting Process.
Schniepp also received the PDA’s Distinguished Service Award in 2008 and its Gordon Personeus Award in 2010, which honors a long-time member for noteworthy contributions to the organization.
As the first woman appointed to serve on the editorial advisory board of Pharmaceutical Technology magazine, Schniepp writes the publication’s quarterly column, “Inside Standards.”
Schniepp holds a bachelor’s of science degree from Northern Illinois University.
OSO BioPharmaceuticals Manufacturing, LLC (osobio.com), is a contract manufacturing organization (CMO) focusing on biologic and pharmaceutical injectables.
Headquartered in Albuquerque, N.M., OsoBio specializes in products requiring complex handling, including highly potent compounds. Responsiveness, attention to detail and clear communication are the hallmarks of our client care.
OsoBio surpasses quality-assurance expectations within our industry. Our employees are industry veterans who provide innovative solutions to our clients’ most difficult projects.